The company has more than 20 production workshops for powder injection preparation, API, solid preparation and Chinese medicine preparation, all of which have passed the national pharmaceutical GMP certification. The company has also passed IS09001, ISO14001 and OHS18001 international quality, environment and occupational health and safety management system certification. The company's products include more than 350 varieties of 10 categories, with an annual output of 2.5 billion vials of powder injection (lyophilized) preparations, 10 billion tablets/granules of solid preparations, 2,000 tons of synthetic sterile raw materials, and 200 million small-volume injections. With the in-depth implementation of the new health insurance and the new rural cooperative reform, the advantages of Ruiyang Pharmaceuticals in terms of numerous production symbols, a complete range of drugs and sufficient production capacity will gradually emerge.
Ruiyang Pharmaceutical insists on taking the market as the center, and highlights the marketing work. Ruiyang Pharmaceutical has a professional marketing team of more than 1,000 people, more than 160 offices throughout the country's large and medium-sized cities, the product has covered the whole country, and is exported to Germany, France, Korea and other more than 30 countries.
The strict quality assurance system is the guarantee for the development of Ruiyang Pharmaceutical. All along, no matter how the external competitive environment changes, Ruiyang Pharmaceutical has always been rigorous, pragmatic attitude, and strive to improve product quality, and constantly improve product quality, casting "Ruiyang" brand. Ruiyang Pharmaceutical adheres to the promise of "quality is the sky", and organizes production in strict accordance with the requirements of the Drug Administration Law, the Code of Practice for the Quality Control of Pharmaceutical Manufacturing and other laws and regulations. It has more than 300 professional quality inspectors and supervisors, a modern quality inspection center and advanced monitoring means, and has also passed the "Measuring Equipment Measurement System Certification" of Shandong Quality and Technical Supervision Bureau. The internal control quality standards of the company's products are higher than the Chinese Pharmacopoeia and other national standards. The company has been responsible for drafting the national drug standards of 42 new drug products, such as Melocillin Sodium, Vasone Suppository and Houpu Exhaust Gas Compound. In the quality inspection of national, provincial and municipal drug supervision (inspection) departments at all levels in the past years, the passing rate of all kinds of product sampling has reached 100%. It has provided a reliable guarantee for the safety and effectiveness of medication for the general public, and "Ruiyang" products have become the commonly used medicines and assured brand for doctors and patients. in September 2010, it was awarded as the advanced unit for the research of the standard of Chinese Pharmacopoeia 2010 edition by the Pharmacopoeia Committee of the Ministry of Health of the People's Republic of China.
Ruiyang Pharmaceutical insists on taking the road of scientific and technological development, and emphasizes the research and development of new products and technologies. The company has established year-round scientific research cooperation with more than 30 universities and research institutes, including Tsinghua University, Shandong University, Shenyang Pharmaceutical University, Tianjin University, Shanghai Medical and Industrial Institute, Shandong Academy of Medical Sciences and so on. Four R&D centers have been set up in the company's headquarter, Jinan, Shanghai and the United States, respectively, and the company's R&D capability and technology level are constantly improving. Up to now, the company has won the second prize of National Scientific and Technological Progress, undertaken two major national new drug innovation special projects, three national torch plan projects; obtained more than 60 patents and more than 60 new drug certificates. Among them, 7 products, such as Melocillin Sodium Preparation for Injection and API, have passed the appraisal of scientific and technological achievements of Shandong Province, and 4 of them have filled the gaps in the country, and the technical level has reached the international leading level; and the new drug, Pueraria Mirifica Granules, has been recognized as a "national key new product". The company's penicillin semi-compound anti-powder injection preparation packaging level, the level of Chinese medicine extraction and cephalosporin API synthesis technology have reached the domestic leading level. On September 15, 2010, Ruiyang Pharmaceutical was honored as the advanced unit of standard research of 2010 edition of Chinese Pharmacopoeia
On November 29, 2010, Ruiyang Pharmaceutical was honored with the Second Prize of National Scientific and Technological Advancement. In order to improve the company's informatization management level, the company has invested more than 15 million yuan in the implementation of ERP, BPM (Project Process Management), ERP, ERP, and BPM (Project Process Management) on top of the backbone of the Gigabyte information platform since 2003. Since 2003, the company has invested more than 15 million RMB to implement ERP (Enterprise Resource Planning), BPM (Project Process), HR (Human Resource) management system, E-MAIL (e-mail) system, TPI information query system, network video conferencing and video monitoring system, and other comprehensive application projects of computer LAN. The use of advanced management tools means that Ruiyang has stepped into the era of digitalization of enterprise management and data-based decision-making.